Weiss Asset Management’s AbbVie ABBV Stock Holding History

Weiss Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.7M	Buy	50,316 +33,551	+200%	+$7.22M	0.13%	119
2026 Q1	$3.65M	Buy	16,765 +12,268	+273%	+$2.72M	0.06%	212
2025 Q4	$1.03M	Buy	+4,497	New	+$1.02M	0.01%	401
2024 Q1	–	Sell	-5,110	Closed	-$792K	–	310
2023 Q4	$792K	Buy	+5,110	New	+$745K	0.04%	172
2022 Q4	–	Sell	-38,508	Closed	-$5.17M	–	538
2022 Q3	$5.17M	Buy	+38,508	New	+$5.53M	0.13%	221
2021 Q3	–	Sell	-66,349	Closed	-$7.47M	–	499
2021 Q2	$7.47M	Buy	+66,349	New	+$7.47M	0.19%	153

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Weiss Asset Management's ABBV Position: Q2 2026 in Review

Weiss Asset Management increased its AbbVie (ABBV) stake by 200% in Q2 2026, buying an estimated $7.22M and bringing the position to 50,316 shares worth $12.7M. The position accounts for 0.13% of the portfolio, ranked #119.

Weiss Asset Management first reported a position in ABBV in Q2 2021 and has held it in 6 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Weiss Asset Management held 50,316 shares of AbbVie worth $12.7M as of Q2 2026.
Weiss Asset Management bought 33,551 AbbVie shares in Q2 2026, an estimated $7.22M.
AbbVie made up 0.13% of Weiss Asset Management's portfolio in Q2 2026, its #119 holding.
Weiss Asset Management first reported a position in AbbVie in Q2 2021 and has held it in 6 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.